Dermal Filler Market Projections 2026 by Top Players Allergan, Merz Pharma, Galderma, Anika Therapeutics, Cytophil, Sinclair Pharma, Suneva Medical

The Dermal Filler Market report research highlights key dynamics of the sector. The potential of the industry has been investigated along with the key challenges. The current market scenario and prospects of the sector has also been studied.

With the growing popularity of dermal filler ‘tweakments’, the international demand for dermal fillers is expected to spiral upward. Browlift, eyelift, and facelift treatments are particularly in vogue. As one grows older, the face loses its subcutaneous fat, resulting in fine facial lines and wrinkles. Heredity, lifestyle factors, and sun exposure can also affect one’s facial skin.

As these products can ensure enhancement of shallow contours, softening of facial creases, plumper lips, improvement of the appearance of recessed scars, dermal fillers act as a crucial part of facial rejuvenation surgeries. The emergence of injectable fillers has been rendering these cosmetic treatments highly convenient of late, as they can offer natural-looking enhancements to make one feel more confident about their appearance.

The following seven key trends have been defining the global dermal filler market forecast:

Face lift applications to gain traction across North America

Face lift treatments have been a popular trend, with increased focus toward self-care, alongside the pandemic-induced attention toward one’s appearance & wellbeing. The application accounted for nearly 20% of the total revenue in the North America dermal filler market during 2019. This noticeable uptick in the procedural frequency can be due to the high level of consciousness regarding facial aesthetics and youthful appearance.

Access sample pages of the report, “North America Dermal Filler Market Forecasts 2026” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1534/sample

Several individuals, particularly women of all ages, have been seeking non-surgical alternatives such as injectable fillers in order to reduce the associated side-effects and pain. Liquid face lifts have especially gained significant approval amongst women, who have been inclined toward constructive facial rejuvenation surgeries.

Increasing number of Americans opting for aesthetic procedures

The U.S. market for dermal fillers has been a thriving industry, recording a revenue of $1.5 billion during 2019. The expansion of individual expenditures on self-care and cosmetic products and treatments, coupled with the high preference for minimally invasive surgeries in the region have been accelerating adoption of these procedures amongst Americans.

As per the findings of the American Society of Plastic Surgeons, more than $17.7 million cosmetic treatments were recorded during 2018, wherein about 15 million of them were minimally invasive surgeries.

Biodegradable dermal filler segment to soar in Asia Pacific

The biodegradable dermal fillers segment is expected to display high adoption in Asian countries through the coming years, and it held the dominant share during the past as well. Biodegradable dermal fillers are of two types: semi-permanent and temporary fillers. This availability of alternatives provides patients with flexibility associated with the frequency and duration of the procedures.

Access sample pages of the report, “Asia Pacific Dermal Filler Market Forecasts 2026” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1547/sample

Growing at an 8% CAGR through 2026, the segment is receiving a boost as these fillers help in decision-making related to permanent fillers treatments, fueling the Asia Pacific market forecast. The benefits accompanying biodegradable dermal fillers such as lesser side effects, lower invasiveness, faster recovery, amongst others, are key factors for consumers.

Increasing facial line correction procedures in APAC

Facial line correction treatments can be an ideal solution for individuals who have been concerned about the appearance of wrinkles and facial lines due to aging, stress, and other factors. The geriatric population in Asia Pacific has been a key consumer pool opting for these treatments. The facial line correction segment in the Asia Pacific dermal fillers industry was estimated at $550 million during 2019 and is likely to accrue higher revenue through 2026.

Japan constitutes of more than 28% of geriatric population and might aid the product consumption.

High volume of aesthetic treatments in India

The market in India is certain to represent a fair portion of the overall APAC dermal filler market share through 2026 and is anticipated to accrue more than $400 million.

The high procedural volume in the region can be attributed to the rising preference for aesthetic treatments that are minimally invasive, which were recorded to be comparatively higher than surgical procedures. Environmental factors including the increasing pollution and exposure to UV rays, alongside the adoption of wrong lifestyles habits such as smoking have been leading to skin aging and deterioration.

High percentage of older population in Europe

The demand for cosmetic procedures has been expanding across the European countries due to the growing awareness pertaining to their availability and benefits. The Europe dermal filler market size is expected to soar as the older population have been opting for minimally invasive procedures to appear youthful. Nearly 20% of the European individuals were aged 65 years or older during 2019.

Hyaluronic acid dermal fillers gather momentum in Europe
The hyaluronic acid dermal fillers segment has been exhibiting high growth rate in the past few months across the European countries. The segment was valued at $1 billion during 2019 and is set to attain a greater share in the upcoming years.

Access sample pages of the report, “Europe Dermal Filler Market Forecasts 2026” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1554/sample
The ease of availability of a wide range of hyaluronic fillers in the market is one of the prominent factors responsible for this trend. Product adoption is also receiving impetus from the development of cross-linked hyaluronic fillers for treating several skin conditions.

Numerous industry participants have been seeking regulatory approvals for their products. For instance, recently, in February 2021, Galderma’s hyaluronic filler, Restylane Defyne, received FDA approval for chin augmentation. Merz Pharma, AbbVie Inc., Huons Global, Sinclair Pharma, Prollenium Medica Technologies, and Galderma are some leading dermal filler producers across the globe.

Contact Us:

Parikhit B.
Corporate Sales,
Graphical Research
Phone: 1-800-986-6917
Email: sales@graphicalresearch.com
Web: https://www.graphicalresearch.com

About Graphical Research:
Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

This release was published on openPR.